The team included Dr. Imad Dweikat, a consultant pediatrician and metabolic diseases, and Dr. Reham Khalaf Nazzal, a researcher in human genomics and neuroscience. The study focused on the clinical results, the results of chemical analyses, and the genetic mutations that cause the rare genetic disease,
Hyperornithinemia, Hyperammonemia, and Homocitrullinuria Syndrome, according to the study, affects at least 200 patients worldwide.